Tibet Cheezheng Tibetan Medicine Co Ltd (002287) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.69 Million ≈ $5.08 Million USD) by net assets (CN¥4.85 Billion ≈ $710.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tibet Cheezheng Tibetan Medicine Co Ltd (002287) defensive interval to measure how many days the company can operate on defensive assets alone.
Tibet Cheezheng Tibetan Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tibet Cheezheng Tibetan Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tibet Cheezheng Tibetan Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Red Cat Holdings Inc
NASDAQ:RCAT
|
-0.134x |
|
Faraday Technology Corp
TW:3035
|
-0.038x |
|
Playa Hotels & Resorts BV
NASDAQ:PLYA
|
0.147x |
|
GPS Participações e Empreendimentos S.A
SA:GGPS3
|
0.069x |
|
Veritex Holdings Inc
NASDAQ:VBTX
|
0.017x |
|
MayAir Technology (China) Co. Ltd. A
SHG:688376
|
N/A |
|
Riyue Heavy Industry Co Ltd
SHG:603218
|
0.076x |
|
Dongfeng Automobile Co Ltd
SHG:600006
|
0.072x |
Annual Cash Flow Conversion Efficiency for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Tibet Cheezheng Tibetan Medicine Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.00 Billion ≈ $731.01 Million |
CN¥729.70 Million ≈ $106.78 Million |
0.146x | +31.54% |
| 2024-12-31 | CN¥4.11 Billion ≈ $601.91 Million |
CN¥456.75 Million ≈ $66.84 Million |
0.111x | -39.62% |
| 2023-12-31 | CN¥3.77 Billion ≈ $551.69 Million |
CN¥693.41 Million ≈ $101.47 Million |
0.184x | +118.09% |
| 2022-12-31 | CN¥3.39 Billion ≈ $495.72 Million |
CN¥285.69 Million ≈ $41.80 Million |
0.084x | -73.76% |
| 2021-12-31 | CN¥3.22 Billion ≈ $471.24 Million |
CN¥1.03 Billion ≈ $151.44 Million |
0.321x | +254.77% |
| 2020-12-31 | CN¥2.63 Billion ≈ $385.52 Million |
CN¥238.65 Million ≈ $34.92 Million |
0.091x | -49.53% |
| 2019-12-31 | CN¥2.26 Billion ≈ $330.99 Million |
CN¥405.95 Million ≈ $59.40 Million |
0.179x | -26.50% |
| 2018-12-31 | CN¥2.05 Billion ≈ $299.28 Million |
CN¥499.40 Million ≈ $73.08 Million |
0.244x | +101.20% |
| 2017-12-31 | CN¥1.89 Billion ≈ $277.12 Million |
CN¥229.83 Million ≈ $33.63 Million |
0.121x | -45.39% |
| 2016-12-31 | CN¥1.75 Billion ≈ $256.28 Million |
CN¥389.20 Million ≈ $56.95 Million |
0.222x | +42.32% |
| 2015-12-31 | CN¥1.65 Billion ≈ $241.61 Million |
CN¥257.81 Million ≈ $37.73 Million |
0.156x | -22.18% |
| 2014-12-31 | CN¥1.55 Billion ≈ $226.77 Million |
CN¥310.95 Million ≈ $45.50 Million |
0.201x | +46.41% |
| 2013-12-31 | CN¥1.45 Billion ≈ $211.92 Million |
CN¥198.48 Million ≈ $29.04 Million |
0.137x | +9.18% |
| 2012-12-31 | CN¥1.35 Billion ≈ $197.79 Million |
CN¥169.67 Million ≈ $24.83 Million |
0.126x | +1466.31% |
| 2011-12-31 | CN¥1.28 Billion ≈ $186.94 Million |
CN¥-11.74 Million ≈ $-1.72 Million |
-0.009x | -111.47% |
| 2010-12-31 | CN¥1.21 Billion ≈ $176.96 Million |
CN¥96.91 Million ≈ $14.18 Million |
0.080x | -47.76% |
| 2009-12-31 | CN¥1.14 Billion ≈ $167.50 Million |
CN¥175.58 Million ≈ $25.69 Million |
0.153x | +23.84% |
| 2008-12-31 | CN¥532.28 Million ≈ $77.89 Million |
CN¥65.93 Million ≈ $9.65 Million |
0.124x | -46.31% |
| 2007-12-31 | CN¥396.33 Million ≈ $58.00 Million |
CN¥91.43 Million ≈ $13.38 Million |
0.231x | +173.63% |
| 2006-12-31 | CN¥456.61 Million ≈ $66.82 Million |
CN¥38.50 Million ≈ $5.63 Million |
0.084x | -- |
About Tibet Cheezheng Tibetan Medicine Co Ltd
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more